About GaloreTx
GaloreTx is a Healthcare company based in Bengaluru (India) founded in 2018 by Raghuveer Ramachandra. Peptide and peptide-based therapies are manufactured using conjugation techniques. The company has 10 employees. Its Indian entity Galoretx Pharmaceuticals Private Limited reported revenue of ₹2.52 Cr. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Proteomics.
Company details
GaloreTx was founded in 2018 in Bengaluru, India, within the biotechnology sector. Cysteine-rich peptides, labeled peptides, derivative peptides, cyclic peptides, and similar products are produced. Solid-phase synthesis and small molecule peptide conjugation methods are employed to create diverse peptide structures. Operations center on therapeutic applications, with manufacturing based in India.
- Headquarters Bengaluru, India
- Employees 10
- Founders Raghuveer Ramachandra
- SectorsHealthcare
- Email••••••••
- Website galoretx.com
- Legal Name Galoretx Pharmaceuticals Private Limited
- Date of Incorporation 12 Jul, 2018
- Jurisdiction Udupi, Karnataka, India
- Annual Revenue₹2.52 Cr
FY 2024 · +41% YoY
- Net Profit₹20.6 Lakh
FY 2024 · 8% margin
- EBITDA₹31.5 Lakh
FY 2024 · 12% margin
- Investors
- Employee Count10
Associated legal entities of GaloreTx
GaloreTx operates through Galoretx Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Galoretx Pharmaceuticals Private Limited CIN U85320KA2018PTC114735 | Active | 12 Jul 2018 | Udupi, Karnataka | ₹2.5 Cr | 10 | 3 | View details |
Funding Insights of GaloreTx
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of GaloreTx with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2018 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in GaloreTx
GaloreTx has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Startup Karnataka.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Support for startups in Karnataka is delivered through policies, funding, and networking services. | 2004 | missionstartupkarnataka.org | Bengaluru, India |
Investor details for GaloreTx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Galoretx Pharmaceuticals Private Limited (GaloreTx)
Galoretx Pharmaceuticals Private Limited is the primary company behind GaloreTx. The board of Galoretx Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Raghuveer Kallajhari Ramachandra, appointed in 2018. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Raghuveer Kallajhari Ramachandra DIN 08178693 | Whole-time director | 12 Jul 2018 | 8 yrs 3 mo | Galoretx Pharmaceuticals Private Limited |
| Chenna Krishna Gundala DIN 09202032 | Director | 06 Feb 2023 | 3 yrs 8 mo | Galoretx Pharmaceuticals Private Limited |
| Sasikumar Govindannair Pottayil DIN 09202031 | Director | 06 Feb 2023 | 3 yrs 8 mo | Galoretx Pharmaceuticals Private Limited |
People of GaloreTx
1 people are tracked at GaloreTx (1 in leadership); the tracked headcount is 10.
| Name | Role | Group |
|---|---|---|
| Founder & Director | Leadership |
Complete people profiles for GaloreTx
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of GaloreTx
Figures of Galoretx Pharmaceuticals Private Limited, the primary company behind GaloreTx, for FY 2024. Revenue was ₹2.52 Cr (+41% year on year). Net profit was ₹20.6 Lakh (8% margin). EBITDA was ₹31.5 Lakh (12% margin). Revenue has grown at a compounded annual rate of +80% over three years and +82% over five years.
- ₹2.52 CrRevenue · FY 2024 · +41% YoY
- ₹20.6 LakhNet profit · 8% margin
- ₹31.5 LakhEBITDA · 12% margin
- ₹1 LakhPaid-up capital
- 10Employees (provident fund records)
- +80%Revenue CAGR, 3 years
- +82%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Galoretx Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for GaloreTx
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of GaloreTx
2 dated milestones of GaloreTx, from founding to its latest funding, stage changes and deals.
- Founded GaloreTx is founded.
- Funding First funding round.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about GaloreTx
GaloreTx was founded in 2018.
GaloreTx is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
GaloreTx has 10 employees.
The primary company behind GaloreTx, Galoretx Pharmaceuticals Private Limited, reported revenue of ₹2.52 Cr for FY 2024, up 41% year on year.
GaloreTx was founded in 2018 in Bengaluru, India, within the biotechnology sector. Cysteine-rich peptides, labeled peptides, derivative peptides, cyclic peptides, and similar products are produced. Solid-phase synthesis and small molecule peptide conjugation methods are employed to create diverse peptide structures. Operations center on therapeutic applications, with manufacturing based in India.
GaloreTx has 1 investor. Key investors include Startup Karnataka.
GaloreTx operates through Galoretx Pharmaceuticals Private Limited.
The legal entities of GaloreTx currently have 3 directors, including Chenna Krishna Gundala, Raghuveer Kallajhari Ramachandra, Sasikumar Govindannair Pottayil.